Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wendong Tang
Overexpression of PEAK1 Contributes to Epithelial–mesenchymal Transition and Tumor Metastasis in Lung Cancer Through Modulating ERK1/2 and JAK2 Signaling
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
O3-16-2The PEAK1-PPP1R12B Axis Inhibits the Development of Colorectal Cancer via Regulating Grb2/Pi3k/Akt Signaling
Annals of Oncology
Medicine
Oncology
Hematology
Related publications
Downregulation of miR-218 Contributes to Epithelial–mesenchymal Transition and Tumor Metastasis in Lung Cancer by Targeting Slug/Zeb2 Signaling
Oncogene
Cancer Research
Genetics
Molecular Biology
Loss of Profilin�2 Contributes to Enhanced Epithelial-Mesenchymal Transition and Metastasis of Colorectal Cancer
International Journal of Oncology
Cancer Research
Oncology
Fas Signaling Promotes Motility and Metastasis Through Epithelial–mesenchymal Transition in Gastrointestinal Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
LincRNA-ROR Induces Epithelial-To-Mesenchymal Transition and Contributes to Breast Cancer Tumorigenesis and Metastasis
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Midkine Induces Epithelial-Mesenchymal Transition Through Notch2/Jak2-Stat3 Signaling in Human Keratinocytes
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
STYK1 Promotes Epithelial-Mesenchymal Transition and Tumor Metastasis in Human Hepatocellular Carcinoma Through MEK/ERK and PI3K/AKT Signaling
Scientific Reports
Multidisciplinary
Overexpression of the Long Noncoding RNA CCAT1 Promotes Metastasis via Epithelial‑to‑mesenchymal Transition in Lung Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
Epithelial-Mesenchymal Transition Leads to NK Cell–mediated Metastasis-Specific Immunosurveillance in Lung Cancer
Journal of Clinical Investigation
Medicine
Interleukin-32α Inactivates JAK2/STAT3 Signaling and Reverses Interleukin-6-Induced Epithelial–mesenchymal Transition, Invasion, and Metastasis in Pancreatic Cancer Cells
OncoTargets and Therapy
Oncology
Pharmacology